Equities research analysts at StockNews.com initiated coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a research note issued on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Price Performance
Shares of XXII opened at $0.18 on Tuesday. The company has a 50-day moving average of $0.39 and a two-hundred day moving average of $2.20. The stock has a market cap of $1.51 million, a price-to-earnings ratio of 0.00 and a beta of 1.39. 22nd Century Group has a one year low of $0.15 and a one year high of $11.04.
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.36) EPS for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 275.12%. The firm had revenue of $7.95 million during the quarter.
Institutional Investors Weigh In On 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Stories
- Five stocks we like better than 22nd Century Group
- Profitably Trade Stocks at 52-Week Highs
- 3 Momentum Trades for October With Ample Upside Ahead
- There Are Different Types of Stock To Invest In
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.